50
Participants
Start Date
December 19, 2019
Primary Completion Date
February 28, 2022
Study Completion Date
April 30, 2022
Elizaria®
Induction cycle: 900 mg (3 vials of 30 mL, 10 mg/mL) intravenous infusion for 30 minutes once a week for 4 weeks. Maintenance therapy: 1200 mg (4 vials of 30 mL, 10 mg/mL) intravenous infusion for 30 minutes in Week 5, followed by 1200 mg every 14 days.
"State budgetary healthcare institution of the city of Moscow Children's City Clinical Hospital of St. Vladimir of the Healthcare Department of the City of Moscow", Moscow
"Federal State Autonomous Educational Institution of Higher Education First Moscow State Medical University n.a. I.M. Sechenov of the Ministry of Health of the Russian Federation", Moscow
"State budgetary healthcare institution of the City of Moscow City clinical hospital #52 of the Moscow City Healthcare Department", Moscow
"State budgetary healthcare institution of the city of Moscow City Clinical Hospital n.a. A.K. Eramishantsev of the Moscow City Healthcare Department", Moscow
"St. Petersburg's State Budgetary Healthcare Institution City Mariinsky Hospital", Saint Petersburg
"St. Petersburg's State Budgetary Healthcare Institution Children's City Multidisciplinary Clinical Specialized Center of High Medical Technologies", Saint Petersburg
"Federal State Budgetary Educational Institution of Higher Education Kazan State Medical University of the Ministry of Health of the Russian Federation", Kazan'
"Regional State Budgetary Healthcare Institution Krasnoyarsk' Regional Clinical Center for Maternity and Childhood Protection", Krasnoyarsk
AO GENERIUM
INDUSTRY